title: PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition.
authors.affiliation: Dermatology Department, University of Rome Tor Vergata, Italy.
authors.forename: Rosita
authors.initials: R
authors.lastname: Saraceno
authors.affiliation: Dermatology Department, University of Rome Tor Vergata, Italy.
authors.forename: Graziella
authors.initials: G
authors.lastname: Babino
authors.affiliation: Dermatology Department, University of Rome Tor Vergata, Italy. Electronic address: chiricozziandrea@gmail.com.
authors.forename: Andrea
authors.initials: A
authors.lastname: Chiricozzi
authors.affiliation: Dermatology Department, University of Rome Tor Vergata, Italy.
authors.forename: Arianna
authors.initials: A
authors.lastname: Zangrilli
authors.affiliation: Dermatology Department, University of Rome Tor Vergata, Italy.
authors.forename: Sergio
authors.initials: S
authors.lastname: Chimenti
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001170:Arthritis, Infectious / Q000188:drug therapy*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D017497:Hidradenitis Suppurativa / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*; D013577:Syndrome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab